Actively Recruiting
Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
Led by National Taiwan University Hospital · Updated on 2026-03-18
30
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.
CONDITIONS
Official Title
Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with somatic symptom disorder (confirmed by psychiatrists)
- Age 20-70
You will not qualify if you...
- Having psychotic symptoms or cognitive impairment
- Having potentially lethal illness
- Using cardiac pacemakers or defibrillators
- Currently pregnant or having plans to become pregnant within the next three months
- Received rTMS treatment within three months
- Cannot read the questionnaires by oneself
- Having to take the following medications persistently: bupropion >300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital Yunlin Branch
Douliu, Yunlin, Taiwan, 640
Actively Recruiting
Research Team
W
Wei-Lieh Huang, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here